Literature DB >> 14574341

Energy metabolism in Bardet-Biedl syndrome.

C Grace1, P Beales, C Summerbell, S A Jebb, A Wright, D Parker, P Kopelman.   

Abstract

INTRODUCTION: Obesity is a consistent presenting feature of the Bardet-Biedl syndrome (BBS), a hereditary disorder caused by a single gene defect. This contrasts sharply with general obesity which, despite a strong hereditary component, has a multifactorial aetiology. For BBS, the phenotypic characterisation of the components of energy balance and the implications for their management remains relatively uninvestigated.
OBJECTIVE: A case-control study to determine whether energy metabolism in subjects with BBS differs from matched obese controls and to inform the clinical management of these patients.
METHODS: A total of 20 overweight and obese subjects with BBS (11 females, 9 males) matched for age, gender and BMI to 20 subjects without BBS. Resting metabolic rate (RMR) was measured by indirect calorimetry, physical activity by CSA accelerometry, body composition by the deuterium dilution technique and dietary intake by 7-day food records.
RESULTS: There was no significant difference between BBS and control subjects in body fat (male: % fat=38, s.d. 2.8 vs 34, s.d. 9.1, female: % fat=45, s.d. 5.9 vs 44, s.d. 8.1; P=0.46] or absolute RMR (male: 6.95, s.d. 1.55 MJ/day vs 7.19, s.d. 1.28 MJ/day; P=0.6). After adjustment for gender, age, fat-free mass and fat mass, there was no significant difference in RMR between BBS and control subjects (F(1, 30)=0.91; P=0.35). A lower level of physical activity was observed in BBS subjects (median cnts/min 259, IQR=153) compared to controls (median cnts/min=306, IQR=119, P=0.02). Reported energy intake, macronutrient composition and magnitude of under-reporting were comparable in both groups.
CONCLUSION: This study reveals no evidence for systematic differences in energy metabolism in subjects with BBS relative to other obese individuals, suggesting that the genetic basis of BBS is not associated with specific abnormalities in energy metabolism. This is an important finding for clinical management and supports the use of energy prescriptions based on RMR for the general obese population plus an appropriate allowance for energy expended via physical activity. Further research is needed on physical activity in BBS.

Entities:  

Mesh:

Year:  2003        PMID: 14574341     DOI: 10.1038/sj.ijo.0802420

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  25 in total

1.  Obesity in patients with Bardet-Biedl syndrome: influence of appetite-regulating hormones.

Authors:  Anja K Büscher; Metin Cetiner; Rainer Büscher; Anne-Margret Wingen; Berthold P Hauffa; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2012-06-05       Impact factor: 3.714

Review 2.  Molecular basis of the obesity associated with Bardet-Biedl syndrome.

Authors:  Deng-Fu Guo; Kamal Rahmouni
Journal:  Trends Endocrinol Metab       Date:  2011-04-21       Impact factor: 12.015

3.  Bardet-Biedl syndrome.

Authors:  Elizabeth Forsythe; Philip L Beales
Journal:  Eur J Hum Genet       Date:  2012-06-20       Impact factor: 4.246

4.  A novel form of ciliopathy underlies hyperphagia and obesity in Ankrd26 knockout mice.

Authors:  Peter Acs; Peter O Bauer; Balazs Mayer; Tapan Bera; Rhonda Macallister; Eva Mezey; Ira Pastan
Journal:  Brain Struct Funct       Date:  2014-03-16       Impact factor: 3.270

5.  Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance.

Authors:  Penelope P Feuillan; David Ng; Joan C Han; Julie C Sapp; Katie Wetsch; Emma Spaulding; Yuqian C Zheng; Rafael C Caruso; Brian P Brooks; Jennifer J Johnston; Jack A Yanovski; Leslie G Biesecker
Journal:  J Clin Endocrinol Metab       Date:  2011-01-05       Impact factor: 5.958

Review 6.  Primary cilia in pancreatic development and disease.

Authors:  Sukanya Lodh; Elizabeth A O'Hare; Norann A Zaghloul
Journal:  Birth Defects Res C Embryo Today       Date:  2014-05-26

Review 7.  The neuropathology of obesity: insights from human disease.

Authors:  Edward B Lee; Mark P Mattson
Journal:  Acta Neuropathol       Date:  2013-10-06       Impact factor: 17.088

8.  Differential effects on β-cell mass by disruption of Bardet-Biedl syndrome or Alstrom syndrome genes.

Authors:  Sukanya Lodh; Timothy L Hostelley; Carmen C Leitch; Elizabeth A O'Hare; Norann A Zaghloul
Journal:  Hum Mol Genet       Date:  2015-10-22       Impact factor: 6.150

Review 9.  Inherited cerebrorenal syndromes.

Authors:  Scott J Schurman; Steven J Scheinman
Journal:  Nat Rev Nephrol       Date:  2009-09       Impact factor: 28.314

10.  Hyperphagia among patients with Bardet-Biedl syndrome.

Authors:  R Sherafat-Kazemzadeh; L Ivey; S R Kahn; J C Sapp; M D Hicks; R C Kim; A J Krause; L B Shomaker; L G Biesecker; J C Han; J A Yanovski
Journal:  Pediatr Obes       Date:  2013-06-18       Impact factor: 4.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.